Novel type 2 oral polio vaccine secures WHO prequalification for broader rollout

The novel type 2 oral polio vaccine (nOPV2), developed by a team including scientists from the Medicines and Healthcare products Regulatory Agency (MHRA), has today (9 January) been quality-assured (prequalified) by the World Health Organization (WHO).

EASEE® receives a “Shark Tank” innovation award from the Epilepsy Foundation – Biotech Investments

Issuer: PRECISIS GmbH / Key word(s): Miscellaneous 20.07.2023 / 15:26 CET/CEST The issuer is solely responsible for the content of this announcement. 26 June 2023:

July 21, 2023

Single-cell profiling reveals immune cell marker and regulator of anti-tumor immunity

B cells are thought to play a critical role in innate and adaptive immunity, but their exact role in anti-tumor immunity remains unknown.

June 24, 2023

Neurofunctional architecture and intention understanding in preschool children

By the age of three, children are capable of understanding others, “mirroring” those they are with to imitate and anticipate their intentions.

July 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.